| |
| |
|
| Insider
Information: |
Berstein David L |
| Relationship: |
SVP, Chief IP Counsel |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
262,115 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
262,115 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Ariad Pharmaceuticals Inc |
ARIA |
SVP, Chief IP Counsel |
2016-03-21 |
262,115 |
2003-09-16 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
76 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, GC and Chief IP Officer |
• • – |
2014-03-19 |
4 |
D |
$8.19 |
$12,334 |
D/D |
(1,506) |
224,642 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Senior VP, Chief IP Officer |
• • – |
2013-03-22 |
4 |
S |
$19.46 |
$31,135 |
D/D |
(1,600) |
189,498 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, GC and Chief IP Officer |
• • – |
2014-03-21 |
4 |
AS |
$7.89 |
$12,630 |
D/D |
(1,600) |
227,042 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, Chief IP Counsel |
• • – |
2015-03-23 |
4 |
AS |
$8.56 |
$17,118 |
D/D |
(2,000) |
159,907 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, Chief IP Counsel |
• • – |
2015-03-23 |
4/A |
AS |
$8.56 |
$17,118 |
D/D |
(2,000) |
226,449 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, Chief IP Counsel |
• • – |
2015-03-20 |
4 |
AS |
$8.85 |
$21,026 |
D/D |
(2,375) |
157,907 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, Chief IP Counsel |
• • – |
2015-03-20 |
4/A |
AS |
$8.85 |
$21,026 |
D/D |
(2,375) |
224,449 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, Chief IP Counsel |
• – – |
2016-03-21 |
4 |
AS |
$6.47 |
$15,356 |
D/D |
(2,375) |
262,115 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Senior VP, Chief IP Officer |
• • – |
2013-04-02 |
4 |
S |
$18.05 |
$43,322 |
D/D |
(2,400) |
208,898 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, GC and Chief IP Officer |
• • – |
2014-04-02 |
4 |
AS |
$8.22 |
$19,718 |
D/D |
(2,400) |
230,642 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, GC and Chief IP Officer |
• • – |
2014-07-15 |
4 |
D |
$5.57 |
$14,527 |
D/D |
(2,608) |
236,034 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Senior VP Chief Patent Counsel |
• – – |
2004-01-07 |
4 |
OE |
$2.00 |
$7,142 |
D/D |
3,571 |
15,753 |
|
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Senior VP, Chief IP Officer |
• • – |
2012-12-18 |
4 |
D |
$20.18 |
$75,836 |
D/D |
(3,758) |
187,098 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Senior VP, Chief IP Officer |
• • – |
2013-03-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,000 |
191,098 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, GC and Chief IP Officer |
• • – |
2014-03-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,000 |
228,642 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, Chief IP Counsel |
• • – |
2015-03-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,000 |
228,449 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, Chief IP Counsel |
• • – |
2015-07-16 |
4 |
AS |
$8.54 |
$34,162 |
D/D |
(4,000) |
230,449 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Senior VP, Chief IP Officer |
• • – |
2013-12-19 |
4 |
AS |
$5.14 |
$23,130 |
D/D |
(4,500) |
221,398 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, GC and Chief IP Officer |
• • – |
2014-03-19 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,750 |
226,148 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, Chief IP Counsel |
• • – |
2015-03-19 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,750 |
226,824 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, Chief IP Counsel |
• – – |
2016-03-19 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,750 |
264,490 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, Chief IP Counsel |
• • – |
2015-09-28 |
4 |
AS |
$6.46 |
$32,316 |
D/D |
(5,000) |
240,449 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, Chief IP Counsel |
• • – |
2015-09-28 |
4/A |
AS |
$6.46 |
$32,316 |
D/D |
(5,000) |
235,449 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Senior VP, Chief IP Officer |
• • – |
2013-04-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,000 |
211,298 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, GC and Chief IP Officer |
• • – |
2014-04-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,000 |
233,042 |
0 |
- |
|
76 Records found
|
|
Page 1 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
